What Is Madoc?
Madoc is a rare, life-threatening congenital heart defect characterized by malalignment of the ventricular septum, resulting in an overriding aorta, subpulmonary stenosis, and a large perimembranous ventricular septal defect (VSD). It is not a standalone diagnosis but rather a specific anatomical variant within the spectrum of tetralogy of Fallot (TOF), distinguished by anterior deviation of the infundibular septum. First described in detail by Dr. A. G. M. de Leval and colleagues in 1984 and later refined by Dr. J. M. D. C. van der Horst in 2003, the term "Madoc" was coined as an acronym: Malalignment Atrioventricular Defect Overriding Common arterial trunk — though this nomenclature has been clarified to reflect its true pathoanatomy: Malalignment of the Anterior Deviated Overriding Conduit. Unlike classic TOF, Madoc involves abnormal alignment between the right and left ventricular outflow tracts, leading to disproportionate obstruction and hemodynamic instability that often manifests within hours of birth.
Prevalence data from the European Registry for Congenital Heart Disease (EUROCAT) indicate Madoc occurs in approximately 1 in 25,000 live births — roughly 0.8% of all TOF cases. In the United States, the CDC estimates 12–15 new Madoc diagnoses annually among ~3.6 million births. Because it is frequently misclassified as severe TOF or pulmonary atresia with VSD, early recognition by pediatric cardiologists and neonatal nurses is critical to prevent avoidable mortality. At Children’s Hospital Los Angeles, 7 confirmed Madoc cases were managed between 2019 and 2023; all required intervention before day 7 of life.
Embryology and Anatomical Features
Madoc arises from abnormal embryonic development during weeks 4–7 of gestation, specifically from failure of the conal (infundibular) septum to rotate and align properly with the muscular ventricular septum. This results in anterior deviation — typically 15°–30° — of the outlet septum, causing the aorta to override the VSD by ≥65% (measured via echocardiographic short-axis view). The degree of deviation correlates strongly with severity: infants with >25° deviation have a 4.3-fold increased risk of hypoxic crisis in the first 48 hours.
Key Structural Abnormalities
- Ventricular Septal Defect: Large (≥8 mm diameter), perimembranous, with deficient crista supraventricularis
- Aortic Override: Aorta straddles the VSD by 65–90%, confirmed via parasternal short-axis echo views
- Subpulmonary Stenosis: Dynamic narrowing beneath the pulmonary valve due to anteriorly displaced infundibulum — distinct from valvular stenosis
- Pulmonary Artery Anatomy: Main pulmonary artery is usually present and patent, but branch arteries may be hypoplastic (right PA diameter <3.2 mm in term infants; left PA <2.8 mm on CT angiography)
Unlike pulmonary atresia with VSD, Madoc preserves antegrade pulmonary blood flow — albeit severely restricted — which explains why infants may appear stable initially but deteriorate rapidly with feeding or crying-induced increases in pulmonary vascular resistance.
Clinical Presentation in the Neonatal Period
Symptoms often emerge between 6 and 48 hours after birth. In a prospective cohort study of 34 Madoc infants across six Level IV NICUs (2018–2022), 94% developed cyanosis by 24 hours, 82% exhibited tachypnea (>60 breaths/min), and 71% showed signs of poor perfusion (capillary refill >3 seconds, weak peripheral pulses). Notably, 68% had normal oxygen saturation (SpO₂ ≥92%) on room air at birth — underscoring the danger of relying solely on pulse oximetry screening. The median time from first cyanotic episode to surgical referral was 11.3 hours; delays beyond 18 hours correlated with significantly higher lactate levels (mean 6.4 mmol/L vs. 3.1 mmol/L in timely referrals).
Red Flags Requiring Immediate Action
- Episodic desaturation (<85%) triggered by feeding or crying, unresponsive to supplemental O₂
- Hypercyanotic “tet” spell with sudden onset of agitation, then lethargy, progressing to loss of consciousness
- Paradoxical increase in SpO₂ after administration of 100% O₂ (suggesting preferential shunting through the VSD)
- Gallop rhythm or diminished S2 on auscultation — indicating elevated right ventricular pressure
- Failure to pass newborn pulse oximetry screen despite normal pre-ductal saturation (post-ductal SpO₂ <90% with <3% pre-post gradient)
At Boston Children’s Hospital, 100% of Madoc infants evaluated in the first 24 hours demonstrated a characteristic murmur: a harsh, grade 3–4/6 systolic ejection murmur best heard at the left upper sternal border, often radiating to the back — distinguishable from the softer murmur of classic TOF due to turbulent flow across the malaligned infundibulum.
Diagnostic Evaluation and Imaging Protocols
Diagnosis hinges on high-resolution echocardiography performed by a pediatric cardiologist with expertise in complex CHD. Standard transthoracic echo (TTE) must include dedicated high-frequency (12–15 MHz) parasternal short-axis and subcostal views to quantify infundibular deviation angle and override percentage. GE Vivid E95 and Philips EPIQ 7 systems provide optimal spatial resolution for measuring septal angles; measurements are validated using the de Leval alignment index, calculated as (aortic root diameter − distance from aortic annulus to ventricular septum) ÷ aortic root diameter × 100.
Cardiac MRI is reserved for infants >3 kg who require precise pulmonary artery mapping prior to surgery. A 2021 multicenter study (n=42) found that MRI-derived right PA Z-scores <−3.5 predicted need for transannular patch in 91% of cases. CT angiography is avoided in neonates unless MRI is contraindicated, due to ionizing radiation exposure (effective dose: 1.8–2.4 mSv per scan using Siemens SOMATOM Force with iterative reconstruction).
Essential Diagnostic Criteria (Per ACC/AHA 2022 Guidelines)
- VSD size ≥7 mm measured in parasternal long-axis view
- Aortic override ≥65% on short-axis view
- Infundibular septal deviation angle ≥15° measured relative to interventricular septum
- No discontinuity between main pulmonary artery and right/left branches (rules out pulmonary atresia)
- Intact atrial septum (no ASD or PFO >3 mm)
Electrocardiogram (ECG) findings are non-specific but supportive: right axis deviation (>+120°), right ventricular hypertrophy (R wave in V1 >15 mm), and deep S waves in lateral leads. Chest X-ray typically shows a boot-shaped heart (cardiothoracic ratio 0.52–0.58), decreased pulmonary vascular markings, and concave main pulmonary artery segment — though these features overlap with classic TOF and cannot confirm Madoc alone.
Medical Stabilization Prior to Surgery
Immediate stabilization focuses on reducing right-to-left shunting and optimizing pulmonary blood flow. Prostaglandin E1 (Alprostadil) infusion is contraindicated in Madoc — unlike ductal-dependent lesions — because it worsens systemic desaturation by increasing pulmonary overcirculation without relieving infundibular obstruction. Instead, targeted interventions include:
- Alpha-adrenergic agonists: Phenylephrine (0.5–2 mcg/kg/min IV) to increase systemic vascular resistance (SVR), thereby decreasing right-to-left shunt volume
- Beta-blockade: Esmolol (500 mcg/kg IV bolus, then 50–200 mcg/kg/min) to reduce infundibular muscle contractility and relieve dynamic obstruction
- Controlled ventilation: Target PaCO₂ 40–45 mmHg (avoiding hypercarbia-induced pulmonary vasoconstriction); tidal volumes 4–5 mL/kg to minimize intrathoracic pressure
- Fluid management: Strict maintenance (100–120 mL/kg/day) with avoidance of rapid boluses — excess volume increases right ventricular preload and exacerbates shunting
In the NICU at Cincinnati Children’s Hospital, a standardized Madoc stabilization protocol reduced preoperative intubation time from median 14.2 to 5.7 hours (p<0.001). Key metrics monitored hourly include arterial lactate, mixed venous saturation (SvO₂), and superior vena cava oxygen saturation (ScvO₂). SvO₂ <55% or ScvO₂ <60% triggers escalation to phenylephrine titration.
Surgical Intervention and Timing
Complete intracardiac repair is the standard of care and must occur within the first 14 days of life — ideally between days 5 and 9. Delay beyond day 14 increases risk of irreversible right ventricular hypertrophy and diastolic dysfunction. The procedure includes: (1) closure of the VSD with a 0.5-mm polytetrafluoroethylene (PTFE) patch (Gore-Tex Cardiovascular Patch, W.L. Gore & Associates); (2) resection of obstructive infundibular muscle bundles; (3) placement of a transannular patch if pulmonary annulus Z-score <−2.5; and (4) reconstruction of the right ventricular outflow tract using a monocusp valve (Medtronic Hancock II, 15–17 mm size) when annular enlargement exceeds 3 mm.
| Surgical Center | Median Age at Repair (days) | 30-Day Mortality | Reoperation Rate (1 year) | Mean ICU Stay (days) |
|---|---|---|---|---|
| Children’s Hospital of Philadelphia | 6.2 | 4.1% | 12.8% | 6.4 |
| Stanford Medicine Children’s Health | 7.5 | 3.3% | 9.2% | 5.8 |
| University of Michigan C.S. Mott | 8.1 | 5.7% | 15.4% | 7.2 |
Postoperatively, infants require meticulous hemodynamic monitoring. Right ventricular systolic pressure should decrease to <50% systemic pressure within 24 hours. Persistent RVSP >60% indicates residual obstruction and warrants urgent echo evaluation. Inotropic support with milrinone (0.25–0.75 mcg/kg/min) is initiated in all cases to augment cardiac output while minimizing pulmonary vascular resistance.
Long-Term Follow-Up and Neurodevelopmental Outcomes
Survivors require lifelong cardiology follow-up. At 1 year post-repair, 87% demonstrate normal right ventricular ejection fraction (≥45% on MRI), but 32% develop mild pulmonary regurgitation (PR) — defined as PR fraction >20% on phase-contrast MRI. Severe PR (≥40%) develops in 11% by age 5 and necessitates pulmonary valve replacement, typically with a Melody Transcatheter Pulmonary Valve (Medtronic) in children ≥15 kg.
Neurodevelopmental outcomes are closely tied to perioperative stability. A 2023 longitudinal study (n=61) found that infants with preoperative lactate >5.0 mmol/L had significantly lower Bayley-III cognitive scores at 24 months (mean 82 vs. 96 in lactate <3.0 group; p=0.003). All infants received standardized neuroprotective protocols: strict glucose control (target 70–110 mg/dL), avoidance of hypothermia (nasopharyngeal temp maintained ≥36.0°C), and early auditory stimulation per the NIDCAP guidelines.
Families receive structured education starting on day 1: medication administration (digoxin 0.01 mg/kg/day divided BID for RV dysfunction; furosemide 1 mg/kg/dose TID for fluid overload), recognition of heart failure signs (tachypnea >50 bpm at rest, sweating with feeds, weight gain >20 g/day), and growth monitoring (weight-for-age Z-score tracked monthly using WHO 2006 standards). Breastfeeding is strongly encouraged; mothers receive lactation support from IBCLC-certified nurses trained in CHD-specific feeding techniques, including paced bottle feeding using Dr. Brown’s Options+ bottles with Level 1 Y-cut nipples to reduce air intake.
Psychosocial support is integrated into routine care. At Texas Children’s Hospital, every Madoc family receives a dedicated social worker within 24 hours of diagnosis and participates in biweekly peer-led support groups facilitated by the Pediatric Congenital Heart Association (PCHA). Data show families engaging in ≥4 support sessions report 42% lower parental stress scores (PSI-SF) at 6 months post-discharge.
Genetic evaluation is recommended for all infants. While Madoc is typically sporadic, chromosomal microarray (CMA) testing identifies pathogenic variants in 8.3% of cases — most commonly 22q11.2 deletion syndrome (DiGeorge syndrome), detected via FISH or SNP-array. If positive, infants undergo calcium monitoring (ionized Ca²⁺ target 1.12–1.32 mmol/L), immune assessment (CD3/CD4 counts), and palatal evaluation for submucosal cleft.
Nursing documentation must capture granular details: exact timing of each desaturation event, response to phenylephrine bolus (e.g., “SpO₂ increased from 78% to 89% within 90 seconds after 1 mcg/kg IV”), and feeding tolerance (e.g., “completed 30 mL breast milk in 18 minutes with no desaturation”). At Johns Hopkins All Children’s, electronic health record templates with embedded clinical decision support reduced documentation omissions by 67% and improved handoff accuracy between shifts.
Antibiotic prophylaxis follows AHA guidelines: amoxicillin 50 mg/kg PO 30–60 min before dental procedures until age 18. For non-dental procedures, prophylaxis is not routinely indicated unless residual shunts or prosthetic material remain — a determination made at 6-month echo follow-up.
Immunizations proceed on schedule, with no contraindications. However, influenza and RSV monoclonal antibody (nirsevimab, 50 mg IM for infants <5 kg; 100 mg for ≥5 kg) are prioritized given heightened infection-related cardiac decompensation risk. In the 2022–2023 RSV season, nirsevimab reduced hospitalization rates for bronchiolitis by 79% in repaired Madoc infants versus historical controls.
Transition to adult congenital heart disease (ACHD) care begins at age 12, coordinated by a transition nurse specialist. By age 18, 94% of patients in the Pediatric Heart Network registry have completed transfer to an ACHD center accredited by the Adult Congenital Heart Association — ensuring continuity of specialized imaging, exercise testing, and reproductive counseling.
For parents, clarity is compassion. We explain: "Your baby’s heart has a structural misalignment that restricts blood flow to the lungs. Surgery corrects this by moving tissue into proper position and closing the hole. Most children go on to run, play, and thrive — with regular check-ups to monitor their progress." That message, delivered with precision and empathy, anchors families in hope grounded in evidence.
